INTRODUCTION
Lysophosphatidic acid (LPA; 1-acyl-sn-glycero-3-phosphate) is a naturally occurring lipid which induces a variety of biological effects, including platelet aggregation [1, 2] , alterations in neuronal cell morphology [3] , induction of smooth-muscle contraction [4, 5] , mediation of a chemotactic response in Dictyostelium [6] , and DNA synthesis and cell division in a number of different cell types [7, 8] . In addition, LPA can regulate secondmessenger production [7] [8] [9] [10] [11] [12] [13] [14] , possibly by interacting with a specific G-protein-coupled receptor that we have recently characterized [15] .
The multiplicity of biological effects of LPA necessitates that the level of this lipid be tightly controlled in order to maintain cellular homoeostasis. Lysophospholipases play an important role in metabolizing lysophospholipids. Several lysophosphatidylcholine-preferring lysophospholipases have been purified from a wide range of cells and tissues [16] [17] [18] [19] [20] [21] [22] . However, none has been shown to hydrolyse LPA preferentially. In this study, we describe the purification and characterization of this novel LPAselective lysophospholipase.
MATERIALS AND METHODS Materials
[3H]Stearoyl-LPA (1-[3H] stearoyl-sn-glycero-3-phosphate; sp. radioactivity 180 Ci/mmol) was generously given by Dr. David Ahern (DuPont-New England Nuclear, Boston, MA, U.S.A.). Non-radioactive stearoyl-LPA (Avanti Polar Lipids, Alabaster, AL, U.S.A.) was used to lower the specific radioactivity of [3H]LPA to 360 ,uCi/mmol. 1-Stearoyl-monoacylglycerol was purchased from Serdary Research Laboratories (London, Ontario, Canada). Other lipids, including 1,2-dipalmitoyl phosphatidic acid, 1-stearoyl-sn-glycero-3-phosphocholine (stearoyl-lysophosphatidylcholine), 1-stearoyl-sn-glycero-3-phosphoethanolamine (stearoyl-lysophosphatidylcholine), 1- oleoyl-sn-glycero-3-phosphate (oleoyl-LPA), 1-myristoyl-sn-glycero-3-phosphate (myristoyl-LPA), I-palmitoyl-sn-glycero-3- were defrosted at room temperature in 20 mM Hepes (pH 8.0)/ 1 mM EDTA (1 brain/4 ml) containing 100 ,ug/ml bacitracin, 10 jtg/ml soybean trypsin inhibitor, 1 mM benzamidine and 1 mM phenylmethanesulphonyl fluoride. The tissue was disrupted by using a Polytron homogenizer, and the resulting homogenate was centrifuged at 10000 g for 30 min at 4 'C. All LPA-hydrolysing lysophospholipase activity was associated with the pellet. Lysophospholipase activity in the pellet was solubilized by homogenzing in n-octyl glucoside (1 %, w/v). The solubilized material was clarified by centrifugation at 100 000 g for 45 Hydrophobic chromatography of a LPA-lysophospholipase
The fractions eluted from the cation column which contained lysophospholipase activity were pooled and further purified by hydrophobic interactive chromatography. (NH4)2SO4 was added to the sample to a final concentration of 1 M. The sample was then applied to a 7.5 mm x 7.5 cm ether-5PW h.p.l.c column (Toso Haas) which had been pre-equilibrated in Buffer A containing 1 M (NH4)2SO4. The protein was eluted by linearly decreasing the concentration of (NH4)2SO4 from 1 M to 0 over a period of25 min, at a flow rate of 1 ml/min throughout. Fractions were collected at 1 min intervals and assayed for lysophospholipase activity. After hydrophobic chromatography, the lysophospholipase was more stable and could be stored on ice overnight without significant loss of activity.
Gel-filtration chromatography of a LPA-lysophospholipase Fluorometric assay of lysophospholipase activity
Hydrolysis of different lysophospholipids by purified lysophospholipase was determined by using the fluorescent fattyacid-binding protein ADIFAB, and non-radiolabelled substrate as described previously [23] . Briefly, the standard reaction mixture contained 4 
Protein measurements
The protein concentration in samples was determined by the method of Bradford [24] , with reagents obtained from Bio-Rad (Richmond, CA, U.S.A.). Samples with a low concentration of protein were quantified by using Quanti-Gold (Diversified Biotech, Newton Center, MA, U.S.A.) as directed by the manufacturer.
RESULTS
Lysophospholipase purification [3H]LPA was readily hydrolysed by rat brain homogenates. All of this enzyme activity was associated with the particulate fraction. The lysophospholipase was quantitatively solubilized by homogenzing the pellet in 1 % n-octyl glucoside, indicating that this enzyme was membrane-associated (Table 1 ). The solubilized material was applied to a cation-exchange h.p.l.c. column. All of the lysophospholipase activity bound to the cation-exchange column. LPA-hydrolysing lysophospholipase activity was eluted as a single peak (Figure 1) . The The purified lysophospholipase from the gel-filtration column was iodinated by using Bolton-Hunter reagent and analysed by SDS/PAGE. The molecular-mass standards (kDa) used were (from top to bottom) phosphorylase b, BSA, aldose, triose phosphate isomerase, trypsin inhibitor and lysozyme.
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.n 100 60 * 50 Qa Figure 3 Gel filtrafton of rat brain lysophospholipase Fractions 13-1 7 from the hydrophobic-interactive column were pooled, concentrated to a final volume of 1 ml by ultrafiltration, applied to the gel-filtration column and eluted. A280 was monitored ( ) and fractions were collected and assayed for lysophospholipase activity (S). The material that was eluted in fractions 11-12 was pooled and used in all subsequent experiments. The molecular-mass standards used were: thyroglobulin, 669 kDa; catalase, 232 kDa; lysozyme, 98 kDa; BSA, 67 kDa; ovalbumin, 43 kDa.
enriched by sequential hydrophobic interactive chromatography ( Figure 2 ) followed by gel-filtration chromatography (Figure 3) . The lysophospholipase activity chromatographed with an apparent molecular mass of approx. 150 kDa. This purification procedure resulted in an enrichment of approx. 23 000-fold, with a final yield of approx. 0.6 % ( Table 1 ). The purity of the isolated lysophospholipase was assessed by SDS/PAGE (Figure 4) . A single band with a molecular mass of 80 kDa was observed.
Lysophospholipase substrate specfficity
The ability of the purified lysophospholipase to hydrolyse a variety of LPAs with different fatty acids in the sn-position and different lysophospholipids was determined by a fluorometric assay [23] . Figure 5 Figure 5 Substrate specificity of purffied rat brain lysophospholipase
The purified lysophospholipase (10 ng/ml) was assayed with the indicated substrates (0, 1-stearoyl-LPA; [1, 1-stearoyl-lyosphosphatidylcholine; A, 1-stearoyl-lysophosphatidylethanolamine; 0, 1-stearoyl-lysophosphatidylinositol; A, 1-stearoyl-lysophosphatidylserine) by a fluorometric method [23] . This assay utilized ADIFAB (4 /4ag/ml) and substrate (5 ,uM) in a buffer consisting of 20 mM Hepes, pH 8.0, and 1 mM EDTA. The data shown are from a single experiment, four of which were performed.
are in agreement with those determined by using 1-[3H]stearoyl-LPA in radiometric assays (Table 1) . LPAs with different sn-l substitutions were used as substrates, and the rates of hydrolysis of this enzyme were calculated (Table 2) . l-Oleoyl-LPA and l-stearoyl-LPA were most readily hydrolysed, followed by 1-palmitoyl-LPA and l-myristoyl-LPA. Other lysophospholipids, such as l-stearoyl-lysophosphatidylcholine, I-stearoyl-lysophosphatidylethanolamine, 1-stearoyl-lysophosphatidylserine and 1-stearoyl-lysophosphatidylinositol, were not hydrolysed by this lysophospholipase ( Figure 5 ). The purified enzyme was unable to hydrolyse other lipids, including phosphatidic acid, phosphatidylcholine, monoacylglycerol and arachidonoyl-CoA when this procedure was used (results not shown). Table 2 Substrate speciclty of purified lysophospholipase Purified lysophospholipase (10 ng/ml) was incubated with the indicated substrates, and the rates of the hydrolysis were quantified by a fluorimetric assay [23] . The data shown above are means+ S.D. from three separate experiments using two different preparations of enzyme. [26] ). Finally this lysophospholipase selectively hydrolysed LPA and had no measurable enzyme activity with other lysophospholipids.
Some of the other lysophospholipases purified to date have had other enzymic activities, such as acyltransferase, transacylase and phospholipase A2 activity (for review see [26] ). The enzyme described here was assayed for these activities; however, no such activity was found. It was also conceivable that the enzyme may have had both a phosphohydrolase and a monoacylglycerol lipase activity. However, since the enzyme had no measurable activity towards monoacylglcycerol, this rather unexpected possibility can be eliminated. Thus we conclude that this enzyme lacks other enzymic activities.
The high degree of substrate specificity of this lysophospholipase has not been observed for any other lysophospholipase studied [23] . In addition to displaying a specificity for the polar head group, the acyl group in the sn-l position determined the rate of LPA catalysis. 1-Oleoyl-LPA and I-stearoyl-LPA were the preferred substrates, followed by 1-palmitoyl-LPA and 1-myristoyl-LPA, which were more slowly hydrolysed. Interestingly, a similar rank order of potencies for these LPAs was observed in both mitogenesis assays [7, 27] and in LPA-receptor affinity assays [15] . Thus this enzyme appears to be ideally suited for terminating LPA's biological effects. Indeed, there is precedence in the literature that showed this to be the case. LPA is known to induce platelet aggregation [1, 28, 29] . Furthermore, 1-O-hexadecyl-sn-glycero-3-phosphate is 30 times more potent than the acyl analogue. One explanation for the observed difference in potencies may be that the acyl derivative is more readily hydrolysed by the enzyme described here, thus decreasing its effective concentration.
Significant quantities of LPA are produced after cell activation [1, 30, 31] and, when released into the extracellular milieu, interact with specific membrane-associated receptors on target cells and tissue [15] . The novel LPA-selective lysophospholipase described here is also membrane-bound, and thus may be in close proximity to the LPA receptor. This potent lipid mediates biological responses that are often associated with inflammatory and proliferative disease (for review see [32] ). It is therefore essential that the LPA signal is terminated to restore balance to the biological system, and the lysophospholipase described here may be crucial in this process.
